EDU 42 - Best Practices in the Multidisciplinary Management of Borderline Resectable and Unresectable Pancreatic Cancer as well as Extrahepatic/Perihilar Cholangiocarcinoma
Borderline and Unresectable Pancreatic Cancer - Role of Ablative Therapies, including Focused Ultrasound and SBRT/SABR
Northwell Health Cancer Institute New Hyde Park, NY, United States
Learning Objectives:
Determine how to better select patients with borderline and unresectable pancreatic cancer and extrahepatic cholangiocarcinoma for combined modality therapy.
Articulate what is the appropriate sequence of systemic and local therapies for borderline resectable pancreatic cancer.
Determine the most appropriate dose fractionation regimen and the role of ablative therapy in unresectable pancreatic cancer and extrahepatic cholangiocarcinoma.
